Literature DB >> 9689453

A-ring reduced derivatives of two synthetic progestins induce anxiolytic effects in ovariectomized rats.

O Picazo1, A Fernández-Guasti, A E Lemus, G A García.   

Abstract

The putative anxiolytic action of the synthetic progestins, norethisterone (NET), levonorgestrel (LNG) and their respective 5 alpha-reduced metabolites, (5 alpha-NET), (3 alpha,5 alpha-NET), (3 beta,5 alpha-NET), (5 alpha-LNG), (3 alpha,5 alpha-LNG) and (3 beta,5 alpha-LNG), were studied in the burying behavior paradigm. From these compounds only 3 alpha,5 alpha-NET and 3 beta,5 alpha-LNG reduced burying behavior without modifying other parameters. Burying behavior latency was prolonged after administration of the highest dose (1.0 mg/rat) of NET and 5 alpha-NET. As a positive control 3 alpha,5 alpha-pregnanolone (allopregnanolone) was included at the same doses used for synthetic steroids. This steroid produced a clear dose-dependent reduction in burying behavior without affecting latency. No steroid with anxiolytic properties affected the general ambulatory behavior. All synthetic steroids with anxiolytic activity proved to be less potent than allopregnanolone. Results are discussed on the basis of the chemical structure requirements necessary to induce tranquilizing effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689453     DOI: 10.1016/s0006-8993(98)00314-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors.

Authors:  M E Rhodes; C A Frye
Journal:  Cogn Affect Behav Neurosci       Date:  2001-09       Impact factor: 3.282

Review 2.  Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

Authors:  Anna-Carin N-Wihlbäck; Inger Sundström-Poromaa; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.